In vitro fertilization (IVF) is the most effective assisted reproductive technology available, but it's also one of the most complex. Unlike simpler treatments such as IUI, a single IVF cycle involves more than a dozen coordinated clinical steps spread across four to six weeks. Understanding each step before you begin reduces anxiety, helps you ask better questions, and prepares you for the physical demands of the process.
This guide walks through the complete IVF process in the order it unfolds, from your initial consultation through your beta hCG blood test. It draws on guidelines published by the American Society for Reproductive Medicine (ASRM).
Overview: The IVF Timeline at a Glance
| Phase | Typical Duration | Key Events |
|---|---|---|
| Consultation and testing | 2–4 weeks | Medical workup, protocol planning |
| Cycle prep / suppression | 1–4 weeks | Birth control pills or Lupron (if long protocol) |
| Ovarian stimulation | 8–14 days | Daily injections, monitoring ultrasounds |
| Trigger shot | 1 night | 36 hours before retrieval |
| Egg retrieval | 1 day | Procedure under sedation |
| Fertilization and culture | 5–7 days | Embryos develop in the lab |
| PGT-A biopsy (optional) | Day 5–6 | Genetic testing of blastocysts |
| Fresh or frozen embryo transfer | 3–5 days post-retrieval (fresh) or later | Embryo placed in uterus |
| Two-week wait (TWW) | ~10–14 days | Progesterone support, waiting |
| Beta hCG blood test | ~10–14 days after transfer | Pregnancy confirmation |
Step 1: Initial Consultation
Your IVF journey begins with a comprehensive consultation with a reproductive endocrinologist (RE). This appointment covers:
- Medical history review: Previous pregnancies, miscarriages, surgeries, known conditions (endometriosis, PCOS, fibroids)
- Partner evaluation: Semen analysis and review of male-factor history
- Fertility goals: Number of children desired, timeline, genetic concerns
- Protocol discussion: Your physician will outline which stimulation approach is appropriate based on your history
The consultation typically lasts 45–90 minutes. Many clinics now offer telemedicine consultations for the initial visit, with in-person testing to follow.
Step 2: Baseline Diagnostic Testing
Before designing your protocol, your care team needs objective data about your ovarian reserve and uterine anatomy. Standard pre-IVF testing includes:
Ovarian reserve assessment:
- AMH (anti-Müllerian hormone): A blood test that reflects your egg supply. AMH below 1.0 ng/mL is considered diminished; above 3.5 ng/mL may indicate PCOS or high responder status.
- Antral follicle count (AFC): A transvaginal ultrasound performed on cycle days 2–4 to count small resting follicles. An AFC of 10–20 reflects normal reserve; <5 suggests diminished reserve.
- Day 3 FSH and estradiol: Elevated FSH (above 10–12 mIU/mL) on day 3 of a natural cycle suggests the pituitary is working harder than normal to recruit follicles, a sign of diminished reserve.
Uterine evaluation:
- Sonohysterogram (SHG): Saline is gently infused into the uterus during ultrasound to visualize the cavity for polyps, fibroids, or scar tissue.
- Hysteroscopy: A camera inserted through the cervix to directly inspect the uterine cavity. Recommended when abnormalities are found on SHG or if there is a history of uterine surgery.
Infectious disease panel: Both partners are screened for HIV, hepatitis B, hepatitis C, syphilis, and in some cases chlamydia and gonorrhea — required by federal law for gamete banking.
Genetic carrier screening: Optional but increasingly recommended. Identifies whether either partner carries genes for conditions like cystic fibrosis, spinal muscular atrophy, or fragile X syndrome.
Step 3: Protocol Selection and Cycle Coordination
Based on your test results and history, your physician prescribes a stimulation protocol. The two most common are:
Antagonist protocol: The most widely used approach today. You start gonadotropin injections on day 2–3 of your menstrual cycle. Around day 5–6, you add a GnRH antagonist (Ganirelix or Cetrotide) to prevent premature ovulation. Stimulation continues for 8–12 days. This protocol is used for most patients and is standard for high and normal responders.
Long Lupron (agonist) protocol: You begin taking Lupron (leuprolide) in the luteal phase of the cycle before your stimulation cycle. This suppresses your pituitary and allows your physician to take full control of follicle development. Stimulation begins after suppression is confirmed on a baseline ultrasound. This protocol is less commonly used today but remains appropriate for certain clinical scenarios.
Estrogen priming protocol: Used for patients with diminished ovarian reserve. Estradiol patches or pills are taken before stimulation starts to "prime" the follicles for better response.
Your coordinator will map out a day-by-day calendar of injections, appointments, and anticipated procedures. Review our IVF medications and injections guide for detailed information on each drug used.
Step 4: Ovarian Stimulation
This is the phase most people associate with IVF — the daily injections. You'll self-administer subcutaneous (under-the-skin) injections into your abdomen each evening, typically for 8–14 days.
What's happening in your body: Gonadotropins (FSH and/or LH) override your natural cycle and stimulate multiple follicles to grow simultaneously. In a natural cycle, one dominant follicle develops and releases a single egg. During IVF stimulation, the goal is to recruit 8–15 follicles.
Monitoring appointments: During stimulation, you'll have transvaginal ultrasounds and estrogen blood draws every 1–3 days. Your physician uses these to track follicle growth and adjust your medication dose. Expect 4–6 monitoring visits.
What to expect physically: Mild bloating and pelvic pressure are common as your ovaries enlarge. Some patients feel emotionally volatile from the hormonal fluctuations. Serious complications are uncommon — the most significant risk is ovarian hyperstimulation syndrome (OHSS), which occurs when the ovaries overrespond. See the IVF medications guide for OHSS prevention strategies.
Step 5: Trigger Shot
When your lead follicles reach approximately 18–20mm in diameter (and there are enough mature-sized follicles), your physician will direct you to administer the "trigger shot" — a final injection that completes the maturation of your eggs and times ovulation precisely.
hCG trigger (Ovidrel, Pregnyl): The most common trigger. Human chorionic gonadotropin mimics the natural LH surge that causes ovulation. Egg retrieval is scheduled exactly 35–36 hours later, just before ovulation would naturally occur.
Lupron trigger (dual trigger): For patients at high risk of OHSS, a GnRH agonist trigger (leuprolide) is used instead of or in addition to hCG. It causes a more physiologic LH surge and dramatically reduces OHSS risk, though progesterone support after retrieval must be intensified.
Timing is critical. The trigger must be given at a specific time — often between 10 PM and midnight — to align retrieval precisely with the 36-hour window.
Step 6: Egg Retrieval
Egg retrieval (oocyte aspiration) is a minor surgical procedure performed in the clinic under IV sedation or monitored anesthesia care (MAC). It takes approximately 15–30 minutes.
The procedure: Using transvaginal ultrasound guidance, your physician inserts a thin needle through the vaginal wall and into each follicle. The fluid in each follicle is aspirated and immediately examined by an embryologist under a microscope to identify eggs.
What you experience: You'll be sedated and will not feel the procedure. You'll rest in recovery for 1–2 hours, then go home with a driver. Mild cramping and spotting are normal for 1–2 days afterward. Full recovery is typically 24–48 hours.
How many eggs are retrieved: The average retrieval in the United States produces 8–15 eggs for a normal responder. Not all eggs will be mature. Typically, 70–80% of retrieved eggs are mature (metaphase II) and suitable for fertilization.
Step 7: Fertilization
In the embryology laboratory, the retrieved eggs are fertilized within a few hours of retrieval using one of two methods:
Conventional insemination: A prepared sperm sample is added to the dish containing the egg in culture media. The sperm fertilize the eggs naturally. Used when semen parameters are normal.
ICSI (intracytoplasmic sperm injection): A single sperm is injected directly into the cytoplasm of each mature egg using a microscopic needle. Used for male-factor infertility (low count, poor motility, poor morphology), previous fertilization failure, or when sperm are surgically retrieved.
The following morning (Day 1), the embryologist checks for fertilization — two pronuclei (one from egg, one from sperm) confirm a fertilized embryo, now called a zygote.
Step 8: Embryo Culture
Fertilized embryos are cultured in specially formulated media in incubators that replicate the conditions of the fallopian tube and uterus. Most clinics now use time-lapse incubators with cameras that photograph embryos every few minutes, allowing embryologists to track development without disturbing the embryos.
Embryo development milestones:
| Day | Stage | What Happens |
|---|---|---|
| Day 0 | Egg retrieval | Mature eggs fertilized |
| Day 1 | 2-pronuclei (2PN) | Fertilization confirmed |
| Day 2 | 4-cell | First cell divisions |
| Day 3 | 6–8 cell | Cleavage stage |
| Day 4 | Morula | Cells compact together |
| Day 5–6 | Blastocyst | Inner cell mass (baby) and trophectoderm (placenta) form |
Most clinics culture embryos to the blastocyst stage (Day 5–6) before transfer or biopsy. Blastocysts have better predictive value for successful implantation than Day 3 embryos.
Attrition is normal. Not every fertilized egg will reach the blastocyst stage. On average, only 40–60% of fertilized eggs become blastocysts. This attrition is natural and reflects biological selection — embryos that stop developing early often had chromosomal abnormalities. Read our embryo grading and PGT-A guide to understand how embryos are scored.
Step 9: PGT-A Testing (Optional)
If you're pursuing preimplantation genetic testing for aneuploidy (PGT-A), a small sample of cells is biopsied from the trophectoderm of each blastocyst on Day 5 or 6. The embryo is then vitrified (frozen), and the biopsy samples are sent to a genetics laboratory.
Results take approximately 7–14 days. Embryos are classified as euploid (chromosomally normal), aneuploid (abnormal), or mosaic (mixed). Only euploid embryos are recommended for transfer.
PGT-A is particularly valuable for women over 37, patients with recurrent implantation failure, or those with a history of recurrent pregnancy loss. However, it is not universally required, and some patients with excellent prognosis elect to skip it to reduce cost and avoid embryo loss from biopsy.
Exploring Options Before IVF?
The IVF process step by step involves significant time, physical demands, and financial investment — which is why many people explore lower-cost interventions first.
MakeAMom makes reusable at-home insemination kits designed for a range of situations: the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with vaginal sensitivities. Kits cost a fraction of clinical treatment and ship discreetly.
Explore home insemination kits at MakeAMom →
Step 10: Embryo Transfer
The embryo transfer is a simple, outpatient procedure that usually takes 5–10 minutes and requires no anesthesia. It is often described as similar to a Pap smear.
The procedure: You arrive with a moderately full bladder (which helps visualize the uterus on abdominal ultrasound). A speculum is placed, and a thin, flexible catheter is loaded with the embryo and passed gently through the cervix into the uterine cavity. The embryologist deposits the embryo, and placement is confirmed on ultrasound. You rest for a short time and then go home.
Fresh vs. frozen transfer: A fresh transfer occurs 3–5 days after egg retrieval, with a cleavage-stage or blastocyst embryo. A frozen embryo transfer (FET) uses a previously cryopreserved embryo and happens in a subsequent cycle. See our frozen embryo transfer guide for details on both approaches.
Single embryo transfer (SET) is now standard for most patients under 38 with good-quality blastocysts. Transferring one embryo at a time significantly reduces twin risk without lowering overall success rates.
Step 11: The Two-Week Wait (TWW)
After transfer, you continue taking progesterone (and often estrogen) to support the uterine lining while you wait for implantation. The period between transfer and your blood test — approximately 10–14 days — is known as the two-week wait.
During this time, home pregnancy tests may be unreliable because:
- Progesterone injections can cause false-positive symptoms
- hCG from the trigger shot may still be detectable for up to 10 days post-trigger
- Early implantation produces low levels of hCG that home tests may not detect reliably
Most physicians advise against home testing before 9–10 days post-transfer, though many patients test at home anyway. Your clinic will instruct you on when to come in for the official blood test.
Step 12: Beta hCG Blood Test
The beta hCG test measures the exact level of human chorionic gonadotropin in your blood — the hormone produced by a developing embryo after implantation.
A positive result (typically hCG >5–10 mIU/mL, with clinic-specific thresholds) is confirmed with a repeat test 48–72 hours later. A normally doubling hCG level strongly suggests a viable early pregnancy. An ultrasound to visualize the gestational sac is usually scheduled for 6–7 weeks of pregnancy.
A negative result means implantation did not occur. Your care team will schedule a follow-up consultation to review the cycle, identify any contributing factors, and plan next steps — which may include another transfer from frozen embryos or a new retrieval cycle.
What Happens If the First Cycle Fails?
A single IVF cycle does not always result in a live birth, and this is not a failure of the process — it reflects the biological reality that not every embryo implants. According to SART data, cumulative live birth rates over multiple cycles are meaningfully higher than per-cycle rates.
After a failed cycle, your physician may recommend:
- Changing the stimulation protocol or medication doses
- PGT-A testing if not already done
- Uterine investigation (ERA testing, hysteroscopy)
- Adjusting the FET protocol
- Donor eggs if ovarian reserve or egg quality is the limiting factor
Frequently Asked Questions
Q: How many eggs are typically retrieved in an IVF cycle? A: The average retrieval in the United States produces 8–15 eggs for a normal responder. Not all eggs are mature — typically 70–80% of retrieved eggs are at the metaphase II (MII) stage and suitable for fertilization. Of those that fertilize, only 40–60% typically develop to blastocyst stage by day 5–6, reflecting normal biological attrition.
Q: What is the difference between a fresh transfer and a frozen embryo transfer? A: A fresh transfer occurs 3–5 days after egg retrieval using an embryo from the same cycle. A frozen embryo transfer (FET) uses a previously cryopreserved embryo in a subsequent cycle, after the body has recovered from stimulation. FETs are now more common because they allow genetic testing (PGT-A), give the body a recovery period, and have shown equivalent or superior outcomes to fresh transfers in many protocols.
Q: What does it mean when embryos "arrest" before blastocyst stage? A: Embryo arrest refers to embryos stopping development before reaching blastocyst stage (day 5–6). This attrition is normal and often reflects chromosomal abnormalities that would have prevented implantation regardless. It does not always indicate a problem with stimulation or the laboratory — it is part of the natural biological selection process that also occurs in natural conception.
Q: Is PGT-A testing required for IVF? A: No, PGT-A is optional. It is particularly valuable for women over 37, patients with recurrent implantation failure, or those with a history of recurrent pregnancy loss. Patients with an excellent prognosis (young age, good embryo quality) may elect to skip it to reduce cost and avoid embryo biopsy risk. Your reproductive endocrinologist can help weigh the benefits for your specific situation.
Q: Why is single embryo transfer now the standard recommendation? A: Single embryo transfer (SET) is recommended because transferring two embryos does not double your chances of pregnancy — cumulative success through two sequential SET transfers approaches the same rate as a double transfer — but dramatically reduces the risk of twin pregnancy. Twin pregnancies carry substantially higher rates of preterm birth, NICU admission, preeclampsia, and other serious complications for both mother and babies.
Key Points
- IVF involves 10–12 distinct clinical steps from consultation to beta hCG
- Monitoring appointments during stimulation are frequent — plan for early morning clinic visits
- Attrition at each stage (retrieval → fertilization → blastocyst → euploid) is expected and reflects normal biology
- Single embryo transfer is the standard of care for most patients
- Cumulative success rates over multiple cycles are significantly higher than single-cycle rates
This article is for informational purposes only and does not constitute medical advice. All treatment decisions should be made in partnership with a board-certified reproductive endocrinologist.
